{"product_id":"tesamorelin","title":"Tesamorelin","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eA growth hormone-releasing hormone (GHRH) analog studied for its effects on GH secretion and visceral adiposity. 10mg liquid vial, third-party verified.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eWhat Is Tesamorelin?\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eTesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. It is one of the few GHRH analogs with regulatory-cleared applications (under the brand name Egrifta) and has been the subject of extensive clinical research examining its effects on growth hormone levels, body composition, and metabolic parameters.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eHistory\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003eTesamorelin was developed by Theratechnologies Inc. and first approved by the FDA in 2010 as Egrifta for a specific clinical application related to lipodystrophy in HIV patients. The compound features a trans-3-hexenoic acid modification on the tyrosine residue, enhancing its stability and biological activity compared to native GHRH. Subsequent research has expanded into broader areas of GH physiology and metabolic science.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"ltr\"\u003e \u003c\/p\u003e","brand":"Protocol Aminos","offers":[{"title":"10MG","offer_id":44807957970989,"sku":null,"price":89.0,"currency_code":"COP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0744\/2232\/1197\/files\/TESAMORALIN_10mg.png?v=1775603407","url":"https:\/\/protocolaminos.com\/products\/tesamorelin","provider":"Protocol Aminos","version":"1.0","type":"link"}